Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance

European Journal of Heart Failure

Volumn 10, Issue 9, 2008, Pages 850-854

  Schulz Menger, Jeanette ^a   Abdel Aty, Hassan ^a   Rudolph, Andre ^a   Elgeti, Thomas ^a   Messroghli, Daniel ^a   Utz, Wolfgang ^a   Boyé, Philipp ^a   Bohl, Steffen ^a   Busjahn, Andreas ^b   Hamm, Bernd ^a   Dietz, Rainer ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HealthTwist GmbH   (Germany)

Author keywords

Cardiovascular magnetic resonance; Gender; Hypertrophic cardiomyopathy; Late gadolinium enhancement

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEX DIFFERENCE;

ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VENTRICULAR REMODELING;

EID: 51349100661     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.06.021     Document Type: Article

References (23)

1. Ghali J.K., Krause-Steinrauf H.J., Adams K.F., et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42 (2003) 2128-2134
2. Mehta P.A., and Cowie M.R. Gender and heart failure: a population perspective. Heart 92 Suppl 3 (2006) iii14-iii18
3. Lampert R., McPherson C.A., Clancy J.F., Caulin-Glaser T.L., Rosenfeld L.E., and Batsford W.P. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 43 (2004) 2293-2299
4. Nicolau J.C., Auxiliadora Ferraz M., Nogueira P.R., Coimbra Garzon S.A., Serrano Jr. C.V., and Ramires J.A. The role of gender in the long-term prognosis of patients with myocardial infarction submitted to fibrinolytic treatment. Ann Epidemiol 14 (2004) 17-23
5. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
6. Olivotto I., Maron M.S., Adabag A.S., et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 480-487
7. Maron B.J., Casey S.A., Hurrell D.G., and Aeppli D.M. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol 91 (2003) 1195-1198
8. Maass A.H., Ikeda K., Oberdorf-Maass S., Maier S.K., and Leinwand L.A. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 110 (2004) 2102-2109
9. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
10. De Castro S., Caselli S., Maron M., et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart 93 (2007) 205-209
11. Schulz-Menger J., Abdel-Aty H., Busjahn A., et al. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 8 (2006) 741-746
12. Dimitrow P.P., Czarnecka D., Strojny J.A., Kawecka-Jaszcz K., and Dubiel J.S. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 77 (2001) 43-48
13. Lin C.L., Chiang C.W., Shaw C.K., Chu P.H., Chang C.J., and Ko Y.L. Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients. Jpn Circ J 63 (1999) 859-864
14. Hudsmith L.E., Petersen S.E., Francis J.M., Robson M.D., and Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7 (2005) 775-782
15. Douglas P.S., Katz S.E., Weinberg E.O., Chen M.H., Bishop S.P., and Lorell B.H. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 32 (1998) 1118-1125
16. Maceira A.M., Prasad S.K., Khan M., and Pennell D.J. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8 (2006) 417-426
17. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
18. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
19. Kim R.J., and Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol 41 (2003) 1568-1572
20. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
21. Li Y., Kishimoto I., Saito Y., et al. Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. Endocrinology 145 (2004) 951-958
22. Tsybouleva N., Zhang L., Chen S., et al. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109 (2004) 1284-1291
23. Spirito P., and Maron B.J. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol 13 (1989) 820-823